As Fed Tightens, Rising Markets Seem to See Easing Ahead
GILD Stock: Gilead Posts Its Best Growth In 7 Years As Cancer Drug Sales Rocket
Gilead Sciences (GILD) crushed fourth-quarter expectations Thursday and issued an unexpectedly bullish outlook that buoyed GILD stock. X The company...